Hypermethylation has been documented in some myeloid disorders including myelodysplastic syndrome (MDS) and in renal cell carcinoma (RCC). A group at the Mayo Clinic noticed the epigenetic marking ...

Ivosidenib (IVO; AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia (R/R AML): Results of a phase 1 study. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This ...

Social worker Marie Brewer talks about the challenges of supporting a loved one with myelodysplastic syndrome (MDS) and ways to find assistance and treatment options. Myelodysplastic syndromes (MDS) ...

LOS ANGELES--(BUSINESS WIRE)-- Phil Dalton, president and CEO of MDS Consulting, will discuss the growing prevalence of hospital and physician partnerships at the annual meeting of the California ...

Patients were treated in the dose-escalation portion of the Phase 1/2 study evaluating seclidemstat in combination with azacitidine Investigators reported a 43% overall response rate among 14 ...

Association between targeted cancer drug net health benefit and uptake, patient out-of-pocket spending, and total spending. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...